MedPath

Follow-up of Ovarian Function in Young Women Who Underwent Ovarian Cortex Cryopreservation

Completed
Conditions
Female Infertility
Interventions
Other: questionnaire
Registration Number
NCT02454829
Lead Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Brief Summary

Evaluation of ovarian function by a questionnaire and by medical file analysis of women and girls who underwent ovarian cortex cryopreservation for fertility preservation between 1997 an 2013 in the investigators' institution in order to evaluate their residual ovarian function. A second part of the questionnaire concerns these women's satisfaction regarding the procedure.

Detailed Description

Between 1997 and december 2013, 546 girls and women underwent ovarian cortex cryopreservation in the investigators' institution for fertility preservation. The main indications were the need for a gonadotoxic treatment, repeated ovarian surgery and a genetic risk for premature ovarian failure . These women will be sent a questionnaire concerning their ovarian function since the procedure and a questionnaire about their satisfaction concerning the procedure. Six different questionnaires will be used adapted to the patient's initial indication for cryopreservation and the patient's age at the time of cryopreservation. Complementary data will be obtained by medical file analysis and by contacting the patient's family doctor or gynecologist.

Data will be correlated with received gonadotoxic treatment and surgical interventions.

The purpose of the study is to improve the indications and patient selection for ovarian cortex cryopreservation.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
546
Inclusion Criteria
  • women who underwent ovarian cortex cryopreservation in our institution between 1997 and 2013
Exclusion Criteria
  • deceased women in this cohort

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Adults, gonadotoxic treatmentquestionnaireWomen 18 years of age or older who underwent ovarian cortex cryopreservation before gonadotoxic treatment (chemotherapy, radiotherapy)
Girls, gonadotoxic treatmentquestionnaireGirls under 18 years of age who underwent ovarian cortex cryopreservation before gonadotoxic treatment (chemotherapy, radiotherapy)
Adults, genetic disordersquestionnaireWomen 18 years of age or older who underwent ovarian cortex cryopreservation in the context of a genetic risk of premature ovarian failure
Adults, ovarian pathologyquestionnaireWomen 18 years of age or older who underwent ovarian cortex cryopreservation for an ovarian pathology not requiring gonadotoxic treatment but surgery
Girls, genetic disordersquestionnaireGirls under 18 years of age who underwent ovarian cortex cryopreservation in the context of a genetic risk of premature ovarian failure
Girls, ovarian pathologyquestionnaireGirls under 18 years of age who underwent ovarian cortex cryopreservation for an ovarian pathology not requiring gonadotoxic treatment but surgery
Primary Outcome Measures
NameTimeMethod
Persistence of ovarian functionsince the cryopreservation procedure (24 up to 216 months)

Prove of ovarian function will be the occurence of pregnancy, the presence of menstrual cycles without hormonal treatment based on the questionnaire or on biological findings compatible with ovarian function in medical file

Secondary Outcome Measures
NameTimeMethod
Satisfaction with the undergone cryopreservation procedureat the time of completion of the questionnaire (24 up to 216 months after the cryopreservation procedure)

The questionnaire will evaluate the patient's satisfaction concerning the cryopreservation procedure

Trial Locations

Locations (1)

Cliniques Universitaires Saint Luc

🇧🇪

Brussels, Belgium

© Copyright 2025. All Rights Reserved by MedPath